Morgan Stanley raised its price target on Intuitive Surgical (NASDAQ: ISRG) to $525.00 (from $500.00) while maintaining a Overweight rating.

Analyst David Lewis says inflection in the core business is obvious given the better than expected procedure growth and material systems upside. The analyst says momentum likely improves heading to the most catalyst rich cycle in the company's history which ought to drive material TAM expansion.